Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2016

  • ID: 3693096
  • Company Profile
  • 125 pages
  • Global Markets Direct
1 of 4
Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2016

Summary

‘Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the Kyowa Hakko Kirin Co., Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Kyowa Hakko Kirin Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Kyowa Hakko Kirin Co., Ltd.
- The report provides overview of Kyowa Hakko Kirin Co., Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Kyowa Hakko Kirin Co., Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Kyowa Hakko Kirin Co., Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Kyowa Hakko Kirin Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Kyowa Hakko Kirin Co., Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Kyowa Hakko Kirin Co., Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Kyowa Hakko Kirin Co., Ltd. Snapshot

Kyowa Hakko Kirin Co., Ltd. Overview

Key Information

Key Facts

Kyowa Hakko Kirin Co., Ltd. - Research and Development Overview

Key Therapeutic Areas

Kyowa Hakko Kirin Co., Ltd. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Kyowa Hakko Kirin Co., Ltd. - Pipeline Products Glance

Kyowa Hakko Kirin Co., Ltd. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Kyowa Hakko Kirin Co., Ltd. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Kyowa Hakko Kirin Co., Ltd. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Kyowa Hakko Kirin Co., Ltd. - Drug Profiles

brodalumab

Product Description

Mechanism of Action

R&D Progress

darbepoetin alfa

Product Description

Mechanism of Action

R&D Progress

granisetron ER

Product Description

Mechanism of Action

R&D Progress

romiplostim

Product Description

Mechanism of Action

R&D Progress

tivozanib hydrochloride

Product Description

Mechanism of Action

R&D Progress

benralizumab

Product Description

Mechanism of Action

R&D Progress

burosumab

Product Description

Mechanism of Action

R&D Progress

istradefylline

Product Description

Mechanism of Action

R&D Progress

mogamulizumab

Product Description

Mechanism of Action

R&D Progress

MT-4580

Product Description

Mechanism of Action

R&D Progress

tivantinib

Product Description

Mechanism of Action

R&D Progress

bardoxolone methyl

Product Description

Mechanism of Action

R&D Progress

bleselumab

Product Description

Mechanism of Action

R&D Progress

KHK-4083

Product Description

Mechanism of Action

R&D Progress

BIW-8962

Product Description

Mechanism of Action

R&D Progress

antithrombin III (human)

Product Description

Mechanism of Action

R&D Progress

entinostat

Product Description

Mechanism of Action

R&D Progress

KHK-2823

Product Description

Mechanism of Action

R&D Progress

KHK-2898

Product Description

Mechanism of Action

R&D Progress

KHK-6640

Product Description

Mechanism of Action

R&D Progress

CHKM-4927

Product Description

Mechanism of Action

R&D Progress

K-685

Product Description

Mechanism of Action

R&D Progress

K-756

Product Description

Mechanism of Action

R&D Progress

KHK-KRAS

Product Description

Mechanism of Action

R&D Progress

KHK-XXX

Product Description

Mechanism of Action

R&D Progress

KM-2812

Product Description

Mechanism of Action

R&D Progress

Pr-1E11

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit ASK1 for Amyotropic Lateral Sclerosis

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit Mitotic Kinesin Eg5 for Ovarian Cancer

Product Description

Mechanism of Action

R&D Progress

Z-3G1

Product Description

Mechanism of Action

R&D Progress

K-777

Product Description

Mechanism of Action

R&D Progress

Small Molecules Targeting Protein-Protein Interactions for Undisclosed Indication

Product Description

Mechanism of Action

R&D Progress

Kyowa Hakko Kirin Co., Ltd. - Pipeline Analysis

Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Target

Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Route of Administration

Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Molecule Type

Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Mechanism of Action

Kyowa Hakko Kirin Co., Ltd. - Recent Pipeline Updates

Kyowa Hakko Kirin Co., Ltd. - Dormant Projects

Kyowa Hakko Kirin Co., Ltd. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

AGS-004

darbepoetin alfa

KHK-2866

KHK-6188

KRN-330

KRX-0601

KW-2449

KW-2450

KW-2478

KW-7158

litronesib

mogamulizumab

pibrozelesin hydrobromide

rocapuldencel-t

SAR-252067

tivantinib

tivozanib hydrochloride

Kyowa Hakko Kirin Co., Ltd. - Company Statement

Kyowa Hakko Kirin Co., Ltd. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Kyowa Hakko Kirin Co., Ltd., Key Information

Kyowa Hakko Kirin Co., Ltd., Key Facts

Kyowa Hakko Kirin Co., Ltd. - Pipeline by Indication, 2016

Kyowa Hakko Kirin Co., Ltd. - Pipeline by Stage of Development, 2016

Kyowa Hakko Kirin Co., Ltd. - Monotherapy Products in Pipeline, 2016

Kyowa Hakko Kirin Co., Ltd. - Partnered Products in Pipeline, 2016

Kyowa Hakko Kirin Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2016

Kyowa Hakko Kirin Co., Ltd. - Out-Licensed Products in Pipeline, 2016

Kyowa Hakko Kirin Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2016

Kyowa Hakko Kirin Co., Ltd. - Pre-Registration, 2016

Kyowa Hakko Kirin Co., Ltd. - Phase III, 2016

Kyowa Hakko Kirin Co., Ltd. - Phase II, 2016

Kyowa Hakko Kirin Co., Ltd. - Phase I, 2016

Kyowa Hakko Kirin Co., Ltd. - Preclinical, 2016

Kyowa Hakko Kirin Co., Ltd. - Discovery, 2016

Kyowa Hakko Kirin Co., Ltd. - Pipeline by Target, 2016

Kyowa Hakko Kirin Co., Ltd. - Pipeline by Route of Administration, 2016

Kyowa Hakko Kirin Co., Ltd. - Pipeline by Molecule Type, 2016

Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Mechanism of Action, 2016

Kyowa Hakko Kirin Co., Ltd. - Recent Pipeline Updates, 2016

Kyowa Hakko Kirin Co., Ltd. - Dormant Developmental Projects,2016

Kyowa Hakko Kirin Co., Ltd. - Discontinued Pipeline Products, 2016

Kyowa Hakko Kirin Co., Ltd., Other Locations

Kyowa Hakko Kirin Co., Ltd., Subsidiaries

List of Figures

Kyowa Hakko Kirin Co., Ltd. - Pipeline by Top 10 Indication, 2016

Kyowa Hakko Kirin Co., Ltd. - Pipeline by Stage of Development, 2016

Kyowa Hakko Kirin Co., Ltd. - Monotherapy Products in Pipeline, 2016

Kyowa Hakko Kirin Co., Ltd. - Partnered Products in Pipeline, 2016

Kyowa Hakko Kirin Co., Ltd. - Pipeline by Top 10 Target, 2016

Kyowa Hakko Kirin Co., Ltd. - Pipeline by Route of Administration, 2016

Kyowa Hakko Kirin Co., Ltd. - Pipeline by Molecule Type, 2016

Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll